Cardiff Oncology Announces Webcast to Discuss Updated Phase 2 CRDF-004 Data for Onvansertib in First-Line RAS-Mutated mCRC

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to Cardiff Oncology Announces Webcast to Discuss Updated Phase 2 CRDF-004 Data for Onvansertib in First-Line RAS-Mutated mCRC
(NASDAQ: CRDF) Delayed: 1.30 +0.09 (7.44%)
Previous Close $1.21    52 Week High $ 
Open $1.28    52 Week Low $ 
Day High $1.43    P/E N/A 
Day Low $1.27    EPS $ 
Volume 1,069,943